Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
No difference in prescription opioid exposure was seen for serum vitamin B12, B6, retinol, or 25-hydroxyvitamin D levels.
Source: 3. Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Women were excluded from analysis if they were pregnant at the time of the NHANES examination, or if they reported any heroin, cocaine, or methamphetamine use in the past year.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Nutritional Status Differs by Prescription Opioid Use among Women of Reproductive Age: NHANES 1999 to 2018
Study design awaiting verification · Nutrients · 2023
Original publication title
Nutritional Status Differs by Prescription Opioid Use among Women of Reproductive Age: NHANES 1999 to 2018
© 2023 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Prescription opioid use among pregnant women has increased in recent years. Prenatal exposure to opioids and poor nutrition can both negatively impact maternal: fetal outcomes. The objective of this study was to characterize the nutrition and health status of reproductive-age women taking prescription opioids, compared to women not taking opioids. Using NHANES 1999 to 2018 data, non-pregnant women aged 20 to 44 years were classified as taking a prescription opioid in the last 30 days (n = 404) or unexposed controls (n = 7234).
Differences in anthropometric, cardiovascular, hematologic, and micronutrient status indicators between opioid-exposed and unexposed women were examined. Opioid-exposed women were older, had lower income and education, and were more likely to be non-Hispanic White, to smoke, and to have chronic health conditions compared to unexposed women. In unadjusted analyses, several nutrition and health markers were significantly different between opioid exposure groups. After controlling for covariates, women taking opioids had higher odds of Class II (OR = 1.6, 95% CI = 1.1 to 2.3) or III obesity (OR = 1.6, 95% CI = 1.1 to 2.5), and lower levels of serum folate, iron, and transferrin saturation.
Reproductive-age women taking prescription opioids may be at risk for poorer nutritional and cardiometabolic health. Future research is needed to explore whether nutritional status impacts maternal: fetal outcomes for women exposed to opioids during pregnancy.
Authors’ abstract
Prescription opioid use among pregnant women has increased in recent years. Prenatal exposure to opioids and poor nutrition can both negatively impact maternal: fetal outcomes. The objective of this study was to characterize the nutrition and health status of reproductive-age women taking prescription opioids, compared to women not taking opioids. Using NHANES 1999 to 2018 data, non-pregnant women aged 20 to 44 years were classified as taking a prescription opioid in the last 30 days (n = 404) or unexposed controls (n = 7234).
Differences in anthropometric, cardiovascular, hematologic, and micronutrient status indicators between opioid-exposed and unexposed women were examined. Opioid-exposed women were older, had lower income and education, and were more likely to be non-Hispanic White, to smoke, and to have chronic health conditions compared to unexposed women. In unadjusted analyses, several nutrition and health markers were significantly different between opioid exposure groups. After controlling for covariates, women taking opioids had higher odds of Class II (OR = 1.6, 95% CI = 1.1 to 2.3) or III obesity (OR = 1.6, 95% CI = 1.1 to 2.5), and lower levels of serum folate, iron, and transferrin saturation.
Reproductive-age women taking prescription opioids may be at risk for poorer nutritional and cardiometabolic health. Future research is needed to explore whether nutritional status impacts maternal: fetal outcomes for women exposed to opioids during pregnancy.
Publication and source details
Original title: Nutritional Status Differs by Prescription Opioid Use among Women of Reproductive Age: NHANES 1999 to 2018
Emily E. Hohman; Tammy E. Corr; Sarah Kawasaki; Jennifer S. Savage; Danielle Symons Downs
Nutrients · 2023
* Correspondence: eeh12@psu.edu© 2023 by the authors.2023https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Pennsylvania State University Social Sciences Research InstituteConsortium on Substance Use and AddictionThis research was funded by the Pennsylvania State University Social Sciences Research Institute and Consortium on Substance Use and Addiction.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T19:41:41.781840+00:00
DOI: 10.3390/nu15081891 · PMC10144164